Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elvira Criado-Moronati"'
Autor:
Niels Werchau, Bettina Kotter, Elvira Criado-Moronati, Andre Gosselink, Nicole Cordes, Dominik Lock, Simon Lennartz, Carolin Kolbe, Nora Winter, Karin Teppert, Fabian Engert, Brian Webster, Joerg Mittelstaet, Daniel Schaefer, Peter Mallmann, Michael R. Mallmann, Dominik Ratiu, Mario Assenmacher, Thomas Schaser, Michael von Bergwelt-Baildon, Pierre Abramowski, Andrew D. Kaiser
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Solid tumors consist of malignant and nonmalignant cells that together create the local tumor microenvironment (TME). Additionally, the TME is characterized by the expression of numerous soluble factors such as TGF-β. TGF-β plays an important role
Externí odkaz:
https://doaj.org/article/c33c72814d7043f49b55860008ccb5cf
Publikováno v:
Journal of Open Source Software. 7:4949
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89e634ab9669e7b07302d400388902ab
https://doi.org/10.21105/joss.04949
https://doi.org/10.21105/joss.04949
Autor:
Hisayoshi Hashimoto, Derya Güngör, Naomi Krickeberg, Johanna Schmitt, Larissa Doll, Marina Schmidt, Sabine Schleicher, Elvira Criado-Moronati, Karin Schilbach
Publikováno v:
Leukemia Research. 117:106842
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa33bd0ceeef08754be186a9811f518b
https://doi.org/10.1016/j.leukres.2022.106842
https://doi.org/10.1016/j.leukres.2022.106842
Publikováno v:
E-Poster Presentations.
Background The adoptive cell transfer (ACT) of tumor-infiltrating T lymphocytes (TILs) has shown remarkable results in patients with different cancer types. The antitumor effect of this therapy is mainly attributed to a small fraction of tumor-reacti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e46fbd706ab7d53104c95460fd6a5114
https://doi.org/10.1136/jitc-2020-itoc7.93
https://doi.org/10.1136/jitc-2020-itoc7.93
Autor:
Anne Richter, Cesar Evaristo, Anna Baranska, Ramona Siemer, Aparajita Singh, Elvira Criado-Moronati, Olaf Hardt, David Agorku, Daniela Vorholt, Philipp Gert, Bianca Heemskerk, Christian Dose
Publikováno v:
Cancer Research. 79:LB-138
Immunotherapy approaches that engage T cells to attack tumors have proven clinical efficacy and tremendous potential in multiple cancers. However, there are several mechanisms of resistance to current therapeutic strategies: clinical benefit is exper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e17da54812432e937bfca17336b90e29
https://doi.org/10.1158/1538-7445.am2019-lb-138
https://doi.org/10.1158/1538-7445.am2019-lb-138
Autor:
Cesar Evaristo, Ramona Siemer, Elvira Criado-Moronati, Anna Baranska, Philipp Gert, David Agorku, Olaf Hardt, Daniela Vorholt, Aparajita Singh, Christian Dose, Bianca Heemskerk, Anne Richter
Publikováno v:
The Journal of Immunology. 202:194.26-194.26
Immunotherapy has proven clinical efficacy and tremendous potential. But clinical benefit is experienced by only a subset of patients, such that additional research is necessary to improve outcomes. In particular, analyze steady-state anti-tumor immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be60246a54fb8d8536f3bb397521b9a0
https://doi.org/10.4049/jimmunol.202.supp.194.26
https://doi.org/10.4049/jimmunol.202.supp.194.26
Autor:
Elvira Criado-Moronati, Lisa Boettcher, Mario Assenmacher, Andrew Kaiser, Christina Maeder, Andrzej Dzionek, Bianca Heemskerk
Publikováno v:
Cancer Immunology Research. 7:B016-B016
Adoptive cell transfer (ACT) of tumor-infiltrating lymphocytes (TILs) has shown remarkable results in patients with metastatic melanoma. However, only a small fraction within the TIL population reacts against the tumor. Therefore, the pre-enrichment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ad877f852e2dbcf9d3b115a65bd55b1
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-b016
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-b016